Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induceangiogenesis (blood vessel generation inside the scaffold).

Biotechnology

Health Care

Spiderwort Inc.

Spiderwort Inc.'s headquarters in Ottawa, Canada

Description

People (7)

Michelle Masson

Scott Jarvis, Virtual CFO

Stephen Hanson

Paula Faria-Tischer

Stephanie De Sante

Yves Gervais

Gloria Snella Agatore

Jobs